The World Health Organization (WHO) may be considering another proposed change to the international scheduling of ketamine, and the American Veterinary Medical Association (AVMA) is seeking the profession’s help in asking the US Food and Drug Administration (FDA) to protect veterinarians’ access to this critical drug. The AVMA is drafting a letter to the FDA that will outline how critical ketamine use is in veterinary medicine and how important it is that it remain available to U.S. veterinarians, and is requesting your help during this urgent time to reinforce the message.

The AVMA has created template letter that will allow you to personalize your response to make more of an impact. Comments are due to the FDA by Oct. 15—this Thursday—and the FDA’s comments will be provided to the 36^th Expert Committee on Drug Dependence (ECDD), which will meet in Geneva Nov. 16-20.

Read more.

Photo Credit: Justine Lee, VETgirl